Back
XBiotech, Inc. 10K Form
Sell
47
XBIT
XBiotech, Inc.
Last Price:
$2.41
Seasonality Move:
9.81%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-09 | 10Q | XBIT/XBiotech, Inc. Quarterly |
| 2023-08-11 | 10Q | XBIT/XBiotech, Inc. Quarterly |
| 2023-05-10 | 10Q | XBIT/XBiotech, Inc. Quarterly |
| 2022-11-09 | 10Q | XBIT/XBiotech, Inc. Quarterly |
| 2022-08-10 | 10Q | XBIT/XBiotech, Inc. Quarterly |
| 2022-05-10 | 10Q | XBIT/XBiotech, Inc. Quarterly |
Receive XBIT News And Ratings
See the #1 stock for the next 7 days that we like better than XBIT
XBIT Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-4.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.48 |
| Price / Book: | 0.45 |
Profitability
| EPS (TTM): | -0.95640 |
|---|---|
| Net Income (TTM): | $-29.2M |
| Gross Margin: | $-1.7M |
| Return on Equity: | -16.39% |
| Return on Assets: | -15.48% |
XBiotech, Inc. Earnings Forecast
Key XBiotech, Inc. Financial Ratios
-
Per Share Earnings over the last 13 years have been positive in 5 years.
XBiotech, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | XBIT |
| CUSIP: | 98400H |
| Website: | xbiotech.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 41.78 |
| Quick Ratio: | 41.34 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
XBIT Technical Analysis vs Fundamental Analysis
Sell
47
XBiotech, Inc. (XBIT)
is a Sell
Is XBiotech, Inc. a Buy or a Sell?
-
XBiotech, Inc. stock is rated a SellThe current XBiotech, Inc. [XBIT] share price is $2.44. The Score for XBIT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.